Effects of Multidisciplinary Rehabilitation on Body Weight Loss Management in Interstitial Lung Disease.

IF 2.6 3区 医学 Q2 RESPIRATORY SYSTEM
Respiration Pub Date : 2026-01-01 Epub Date: 2025-10-10 DOI:10.1159/000548818
Taichi Kaneko, Atsuhito Nakazawa, Eri Hagiwara, Yoichi Tagami, Tsuneyuki Oda, Akimasa Sekine, Shigeru Komatsu, Takeshi Kaneko, Takashi Ogura
{"title":"Effects of Multidisciplinary Rehabilitation on Body Weight Loss Management in Interstitial Lung Disease.","authors":"Taichi Kaneko, Atsuhito Nakazawa, Eri Hagiwara, Yoichi Tagami, Tsuneyuki Oda, Akimasa Sekine, Shigeru Komatsu, Takeshi Kaneko, Takashi Ogura","doi":"10.1159/000548818","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Body weight (BW) loss is common in interstitial lung disease (ILD) patients and correlated with poor prognosis. This study aimed to verify whether multidisciplinary interventions combining pulmonary rehabilitation and nutritional management affect BW loss and prognosis in ILD.</p><p><strong>Methods: </strong>We retrospectively examined changes in body composition including BW in ILD patients who were admitted to our hospital for the comprehensive pulmonary rehabilitation program. These parameters were measured 6 months before, at the beginning, and 6 months after the program. We investigated the program's impact on BW loss and its association with survival.</p><p><strong>Results: </strong>Of the 169 program participants, 40 ILD patients with tracked BW trends were enrolled. A significant BW loss was observed during 6 months before the program (p < 0.001); however, the intervention successfully halted further BW loss (p = 0.116). Patients on antifibrotic medications also showed similar BW trends. Notably, patients with pleuroparenchymal fibroelastosis showed a significant BW loss before the program (-1.8 kg, p < 0.001) but exhibited BW gain following the intervention (+1.0 kg, p = 0.475). Regarding the survival, BW loss halted group (effective group) had a significantly longer survival (log rank, p = 0.022). In multivariate analysis, BW loss >5% was identified as a prognostic indicator. This program successfully halted BW loss and increased survival.</p><p><strong>Conclusion: </strong>Multidisciplinary rehabilitation effectively managed BW, leading to better survival in ILD. In particular, there is currently no treatment for pleuroparenchymal fibroelastosis, and multidisciplinary rehabilitation offers a promising treatment option.</p>","PeriodicalId":21048,"journal":{"name":"Respiration","volume":" ","pages":"339-349"},"PeriodicalIF":2.6000,"publicationDate":"2026-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Respiration","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1159/000548818","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/10/10 0:00:00","PubModel":"Epub","JCR":"Q2","JCRName":"RESPIRATORY SYSTEM","Score":null,"Total":0}
引用次数: 0

Abstract

Introduction: Body weight (BW) loss is common in interstitial lung disease (ILD) patients and correlated with poor prognosis. This study aimed to verify whether multidisciplinary interventions combining pulmonary rehabilitation and nutritional management affect BW loss and prognosis in ILD.

Methods: We retrospectively examined changes in body composition including BW in ILD patients who were admitted to our hospital for the comprehensive pulmonary rehabilitation program. These parameters were measured 6 months before, at the beginning, and 6 months after the program. We investigated the program's impact on BW loss and its association with survival.

Results: Of the 169 program participants, 40 ILD patients with tracked BW trends were enrolled. A significant BW loss was observed during 6 months before the program (p < 0.001); however, the intervention successfully halted further BW loss (p = 0.116). Patients on antifibrotic medications also showed similar BW trends. Notably, patients with pleuroparenchymal fibroelastosis showed a significant BW loss before the program (-1.8 kg, p < 0.001) but exhibited BW gain following the intervention (+1.0 kg, p = 0.475). Regarding the survival, BW loss halted group (effective group) had a significantly longer survival (log rank, p = 0.022). In multivariate analysis, BW loss >5% was identified as a prognostic indicator. This program successfully halted BW loss and increased survival.

Conclusion: Multidisciplinary rehabilitation effectively managed BW, leading to better survival in ILD. In particular, there is currently no treatment for pleuroparenchymal fibroelastosis, and multidisciplinary rehabilitation offers a promising treatment option.

多学科康复对间质性肺疾病减重管理的影响。
背景与目的:体重(BW)下降在间质性肺疾病(ILD)患者中很常见,并与不良预后相关。本研究旨在验证肺康复和营养管理相结合的多学科干预是否会影响肺重损失和ILD的预后。方法:我们回顾性研究了在我院接受综合肺部康复治疗的ILD患者的身体组成变化,包括BW。这些参数分别在治疗前6个月、开始时和治疗后6个月进行测量。我们调查了该计划对体重损失的影响及其与生存的关系。结果:在169名项目参与者中,40名追踪BW趋势的ILD患者入组。在计划前6个月观察到显著的体重损失(p < 0.001);然而,干预成功地阻止了体重的进一步下降(p = 0.116)。服用抗纤维化药物的患者也表现出类似的BW趋势。值得注意的是,胸膜实质纤维弹性增生患者在治疗前体重明显减少(- 1.8 kg, p < 0.001),但在治疗后体重增加(+ 1.0 kg, p = 0.475)。在生存期方面,体重减少停止组(有效组)的生存期明显延长(log-rank, p = 0.022)。在多变量分析中,体重损失bb0.5 %被确定为预后指标。这个项目成功地阻止了生物体重的损失,提高了存活率。结论:多学科康复治疗有效地治疗了BW,提高了ILD患者的生存率。特别是,目前没有治疗胸膜实质纤维弹性增生的方法,多学科康复提供了一个有希望的治疗选择。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Respiration
Respiration 医学-呼吸系统
CiteScore
7.30
自引率
5.40%
发文量
82
审稿时长
4-8 weeks
期刊介绍: ''Respiration'' brings together the results of both clinical and experimental investigations on all aspects of the respiratory system in health and disease. Clinical improvements in the diagnosis and treatment of chest and lung diseases are covered, as are the latest findings in physiology, biochemistry, pathology, immunology and pharmacology. The journal includes classic features such as editorials that accompany original articles in clinical and basic science research, reviews and letters to the editor. Further sections are: Technical Notes, The Eye Catcher, What’s Your Diagnosis?, The Opinion Corner, New Drugs in Respiratory Medicine, New Insights from Clinical Practice and Guidelines. ''Respiration'' is the official journal of the Swiss Society for Pneumology (SGP) and also home to the European Association for Bronchology and Interventional Pulmonology (EABIP), which occupies a dedicated section on Interventional Pulmonology in the journal. This modern mix of different features and a stringent peer-review process by a dedicated editorial board make ''Respiration'' a complete guide to progress in thoracic medicine.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书